Edgen Stock·Dec 09 2025, 00:58Back
New Obesity Drug Data Challenges Market Leaders
Edgen Stock·Dec 09 2025, 00:58
[1] China's Ascletis reports 7.7% weight loss for oral GLP-1 contender in US phase 2 study - Fierce Biotech (https://www.fiercebiotech.com/biotech/chinas- ...)[2] Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment - Reuters (https://www.reuters.com/business/healthcare-p ...)[3] Evotec (EVO) closes Toulouse sale with potential US$ 650 m+ and royalties - Stock Titan (https://www.stocktitan.net/news/EVO/evotec-cl ...)
